The Y-box-binding protein, YB1, is a potential negative regulator of the p53 tumor suppressor (Q28564441)

2

1 reference

31 January 2017

Craig Homer

4

1 reference

31 January 2017

You Fang Zhang

5

1 reference

31 January 2017

J. Greg Murison

6

1 reference

31 January 2017

Antony W. Braithwaite

7

1 reference

31 January 2017

James Watson

Journal of Biological Chemistry

8

1 reference

31 January 2017

language of work or name

English

0 references

publication date

12 September 2003

1 reference

31 January 2017

1 reference

31 January 2017

278

1 reference

31 January 2017

37

1 reference

31 January 2017

35516–35523

1 reference

31 January 2017

Mechanisms and genes of cellular suicide

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Cancer. p53, guardian of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

P53, cell cycle control and apoptosis: implications for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

14-3-3sigma is a p53-regulated inhibitor of G2/M progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

A model for p53-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Gene regulation by Y-box proteins: coupling control of transcription and translation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Regulation of the human fas promoter by YB-1, Puralpha and AP-1 transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Structural and functional properties of the evolutionarily ancient Y-box family of nucleic acid binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

E1A control of gene expression is mediated by sequences 5' to the transcriptional starts of the early viral genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Identification of an upstream region of the mouse p53 promoter critical for transcriptional expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Human p53 oncogene contains one promoter upstream of exon 1 and a second, stronger promoter within intron 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Dual blockade of cyclic AMP response element- (CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonucleotide. gene-specific inhibition of tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Nuclear translocation of the Y-box binding protein by ultraviolet irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Two human genes isolated by a novel method encode DNA-binding proteins containing a common region of homology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Transcriptional activation of the human epidermal growth factor receptor promoter by human p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

A role for Y-box proteins in cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Molecular interactions between single-stranded DNA-binding proteins associated with an essential MCAT element in the mouse smooth muscle alpha-actin promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Reciprocal interaction between two cellular proteins, Puralpha and YB-1, modulates transcriptional activity of JCVCY in glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

The rat poly pyrimidine tract binding protein (PTB) interacts with a single-stranded DNA motif in a liver-specific enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Nuclear localization of Y-box factor YB1 requires wild-type p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Combinatorial interactions of p53, activating protein-2, and YB-1 with a single enhancer element regulate gelatinase A expression in neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Splicing factor SRp30c interaction with Y-box protein-1 confers nuclear YB-1 shuttling and alternative splice site selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200

Compromised HOXA5 function can limit p53 expression in human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303920200